#89 - Cash-Pay Telemedicine’s Secret: White Labels, Call Centers & Who Really Owns the Risk

From Telemedicine Talks · 00:33:01

Show by Phoebe Gutierrez, Dr. Leo Damasco, Doctor Podcast Network

In this candid episode of Telemedicine Talks, host Phoebe Gutierrez welcomes healthcare attorney Brigid Maloney for a deep dive into the compliance landmines facing cash-pay telemedicine companies.They discuss the flood of low-barrier platforms launched by marketers and coders who don’t understand clinical or regulatory rules, the marketing of unapproved substances like BPC-157, and the rise of white-label telemedicine companies that obscure physician accountability. Brigid highlights emerging trends such as non-licensed, sometimes offshore, call centers performing triage and the difficulty patients face reaching the original treating clinician.The conversation covers upcoming regulatory shifts like DEA telemedicine registration for controlled substances, California’s private-equity ownership approval requirements, and growing medical-board scrutiny, while debating whether meaningful enforcement will come from federal agencies or the states. They stress the importance of physician involvement in governance, rigorous vendor and influencer due diligence, and building compliant systems from day one rather than trying to retrofit them later.Listeners leave with a clear message: in cash-pay telemedicine, the physician’s license remains the ultimate backstop. Companies that treat doctors as true partners, protect patients, and prioritize compliance from the start are the ones positioned to last.Three Actionable Takeaways:Low barriers to entry have created widespread naiveté: Many cash-pay platforms market unapproved products or rely on white-label clinicians and non-licensed call centers that put patient safety and physician licenses at risk.Enforcement is more likely to come from state medical boards and new state-level guardrails (ownership disclosure, PE approvals, network reporting) than from federal agencies, but the volumes in telemedicine mean fines can escalate rapidly.Build compliance and true physician partnerships into the model from day one, involve PC shareholders in governance, conduct real vendor/influencer due diligence, and remember that everything ultimately falls on the doctor’s license.About the Show:Telemedicine Talks explores the evolving world of digital health, helping physicians navigate new opportunities, regulatory challenges, and career transitions in telemedicine.About the Guest:Brigid Maloney is a healthcare attorney specializing in digital health, telemedicine, MSOs, and corporate practice of medicine issues. She advises telemedicine platforms and physician groups on compliance, contracting, marketing arrangements, and regulatory risk, and serves as personal counsel to the hosts of Telemedicine Talks.About the Host:Phoebe Gutierrez – Former state regulator turned telehealth executive, specializing in compliance and sustainable virtual care models.Connect with Phoebe Gutierrez:https://www.linkedIn.com/in/pkgutierrez/ [email protected] (mailto:[email protected]) The information provided in Telemedicine Talks is for educational and informational purposes only and should not be construed as medical, legal, or financial advice. While we discuss best practices, industry trends, and real-world experiences, every situation is unique. Listeners should consult with qualified professionals before making decisions related to telemedicine practice, compliance, contracts, or business operations. The views expressed by the hosts and guests are their own and do not necessarily reflect those of any organizations they may be affiliated with. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

More episodes of Telemedicine Talks

More episodes

PodSearch is a free, independent podcast search engine. Read about PodSearch, the privacy policy or contact us.